ELI LILLY AND COMPANY Common Stock, Shares Held in Employee Trust, Shares
ELI LILLY AND COMPANY (LLY) had Common Stock, Shares Held in Employee Trust, Shares of 50.00 million shares as of 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Notes › Equity › Stockholders' Equity Note › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesHeldInEmployeeTrustShares · last filed 2026-02-12
- 2025-12-31: Common Stock, Shares Held in Employee Trust, Shares 50.00M shares.
- 2024-12-31: Common Stock, Shares Held in Employee Trust, Shares 50.00M shares.
- 2023-12-31: Common Stock, Shares Held in Employee Trust, Shares 50.00M shares.
- 2022-12-31: Common Stock, Shares Held in Employee Trust, Shares 50.00M shares.
| Period end | Common Stock, Shares Held in Employee Trust, Shares |
|---|---|
| 2025-12-31 | 50.00M shares 10-K · filed 2026-02-12 |
| 2024-12-31 | 50.00M shares 10-K · filed 2026-02-12 |
| 2023-12-31 | 50.00M shares 10-K · filed 2025-02-19 |
| 2022-12-31 | 50.00M shares 10-K · filed 2024-02-21 |
| 2021-12-31 | 50.00M shares 10-K · filed 2023-02-22 |
| 2020-12-31 | 50.00M shares 10-K · filed 2022-02-23 |
| 2019-12-31 | 50.00M shares 10-K · filed 2021-02-17 |
| 2018-12-31 | 50.00M shares 10-K · filed 2020-02-19 |
| 2017-12-31 | 50.00M shares 8-K · filed 2019-10-24 |
| 2016-12-31 | 50.00M shares 10-K · filed 2018-02-20 |
| 2015-12-31 | 50.00M shares 10-K · filed 2017-02-21 |
| 2014-12-31 | 50.00M shares 10-K · filed 2016-02-19 |
| 2013-12-31 | 50.00M shares 10-K · filed 2015-02-19 |
| 2012-12-31 | 50.00M shares 10-K · filed 2014-02-19 |
| 2011-12-31 | 50.00M shares 10-K · filed 2013-02-21 |
| 2010-12-31 | 50.00M shares 10-K · filed 2012-02-24 |
| 2009-12-31 | 50.00M shares 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |